Literature DB >> 11427176

Mortality and cancer incidence in persons with Down's syndrome, their parents and siblings.

C Hermon1, E Alberman, V Beral, A J Swerdlow.   

Abstract

A cohort study of 1425 persons with Down's syndrome (DS), and of their parents (447 mothers, 435 fathers) and siblings (1176), was set up to investigate death rates from various causes and cancer incidence patterns. In individuals with DS the all-cause death rate was six times that of the national population (SMR = 622: 95% CI 559-693), the excess being attributable to many different causes. These included: leukaemia (SMR = 1304: 95% CI 651-2334); diabetes mellitus (SMR = 982: 95% CI 267-2515); Alzheimer's disease (SMR = 22028: 95% CI 7137-51326); epilepsy (SMR = 1727: 95% CI 744-3403); and congenital anomalies (SMR = 4987: 95% CI 4175-5955). The overall survival showed marked improvements for successive birth cohorts, particularly at young ages. For mothers and fathers of persons with DS, all-cause death rates were 20% lower than national rates and there were no significant excesses from any specific cause. For siblings, all-cause death rates were similar to national rates; the only condition with a significantly raised mortality ratio was colo-rectal cancer (SMR = 793: 95% CI 216-2031), but this may well be a chance finding.

Entities:  

Mesh:

Year:  2001        PMID: 11427176     DOI: 10.1017/S0003480001008508

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  15 in total

1.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

2.  Body Composition and BMI Growth Charts in Children With Down Syndrome.

Authors:  Jacquelyn A Hatch-Stein; Babette S Zemel; Divya Prasad; Heidi J Kalkwarf; Mary Pipan; Sheela N Magge; Andrea Kelly
Journal:  Pediatrics       Date:  2016-09-14       Impact factor: 7.124

3.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

Review 4.  Health disparities between women with and without disabilities: a review of the research.

Authors:  Jennifer P Wisdom; Marjorie G McGee; Willi Horner-Johnson; Yvonne L Michael; Elizabeth Adams; Michelle Berlin
Journal:  Soc Work Public Health       Date:  2010-05

5.  Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease.

Authors:  Oliver Stöhr; Katharina Schilbach; Lorna Moll; Moritz M Hettich; Susanna Freude; F Thomas Wunderlich; Marianne Ernst; Johanna Zemva; Jens C Brüning; Wilhelm Krone; Michael Udelhoven; Markus Schubert
Journal:  Age (Dordr)       Date:  2011-11-06

6.  Cause of death in adults with Down syndrome in the United States.

Authors:  Scott D Landes; J Dalton Stevens; Margaret A Turk
Journal:  Disabil Health J       Date:  2020-06-10       Impact factor: 2.554

Review 7.  Stem and progenitor cell dysfunction in human trisomies.

Authors:  Binbin Liu; Sarah Filippi; Anindita Roy; Irene Roberts
Journal:  EMBO Rep       Date:  2014-12-17       Impact factor: 8.807

Review 8.  Aspects of digestive tract tumors in Down syndrome: a literature review.

Authors:  Daniel Satgé; Annie J Sasco; Michel J J Vekemans; Marie-Laure Portal; Jean-François Fléjou
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

9.  Cardiometabolic Risk and Body Composition in Youth With Down Syndrome.

Authors:  Sheela N Magge; Babette S Zemel; Mary E Pipan; Samuel S Gidding; Andrea Kelly
Journal:  Pediatrics       Date:  2019-07-17       Impact factor: 7.124

10.  A study protocol of a randomised controlled trial to investigate if a community based strength training programme improves work task performance in young adults with Down syndrome.

Authors:  Nora Shields; Nicholas F Taylor; Bo Fernhall
Journal:  BMC Pediatr       Date:  2010-03-25       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.